Challenges in Respiratory Syncytial Virus in Adults With Severe Community-acquired Pneumonia.
Rello J, Sabater-Riera J.
Chest. 2022 Jun;161(6):1434-1435. doi: 10.1016/j.chest.2022.01.050.
Community-Acquired Pneumonia in Children.
Leung AKC, Wong AHC, Hon KL.
Recent Pat Inflamm Allergy Drug Discov. 2018;12(2):136-144. doi: 10.2174/1872213X12666180621163821.
IGF1R is an entry receptor for respiratory syncytial virus.
Griffiths CD, Bilawchuk LM, McDonough JE, Jamieson KC, Elawar F, Cen Y, Duan W, Lin C, Song H, Casanova JL, Ogg S, Jensen LD, Thienpont B, Kumar A, Hobman TC, Proud D, Moraes TJ, Marchant DJ.
Nature. 2020 Jul;583(7817):615-619. doi: 10.1038/s41586-020-2369-7. Epub 2020 Jun 3.
Respiratory syncytial virus infection in COVID-19 times: Trick or threat?
Menasalvas Ruiz AI.
Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jun-Jul;41(6):319-320. doi: 10.1016/j.eimce.2023.01.006. Epub 2023 Apr 17.
Respiratory syncytial virus pneumonia in an immunocompetent adult: an important differential diagnosis of COVID-19.
Tone K, Gochi M, Kuwano K.
QJM. 2022 Dec 12;115(12):868-869. doi: 10.1093/qjmed/hcac205.
Infant Respiratory Syncytial Virus Bronchiolitis and Subsequent Risk of Pneumonia, Otitis Media, and Antibiotic Utilization.
Abreo A, Wu P, Donovan BM, Ding T, Gebretsadik T, Huang X, Stone CA, Turi KN, Hartert TV.
Clin Infect Dis. 2020 Jun 24;71(1):211-214. doi: 10.1093/cid/ciz1033.
Respiratory Syncytial Virus Pediatric Hospitalization in the COVID-19 Era.
Bozzola E, Barni S, Villani A.
Int J Environ Res Public Health. 2022 Nov 22;19(23):15455. doi: 10.3390/ijerph192315455.
Respiratory syncytial virus infection in cattle.
Sacco RE, McGill JL, Pillatzki AE, Palmer MV, Ackermann MR.
Vet Pathol. 2014 Mar;51(2):427-36. doi: 10.1177/0300985813501341. Epub 2013 Sep 5.
Lymphocyte subset changes in neonates with respiratory syncytial virus pneumonia.
Zou P, Li G, Ge X, Wang J, Wang X, Li Y, Liu Y, Zhang J, Gui J, Wang Y.
J Infect. 2022 Sep;85(3):334-363. doi: 10.1016/j.jinf.2022.05.025. Epub 2022 May 24.
Post-immunobiotics increase resistance to primary respiratory syncytial virus infection and secondary pneumococcal pneumonia.
Tonetti FR, Tomokiyo M, Fukuyama K, Elean M, Moyano RO, Yamamuro H, Shibata R, Quilodran-Vega S, Kurata S, Villena J, Kitazawa H.
Benef Microbes. 2023 Feb 1;14(3):209-221. doi: 10.3920/BM2022.0118.
